Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C)

Competing Interest Statement

Dr. Bennett reported receiving grants from the National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) during the conduct of the study and grants from the NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development and NIH/National Institute of Allergy and Infectious Diseases outside the submitted work. Dr. Moffitt reported receiving grants from the NIH during the conduct of the study. Dr. Hajagos reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Bradwell reported being employed by Palantir Technologies during the conduct of the study and outside the submitted work. Ms. Gabriel reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Girvin reported being an employee of Palantir Technologies. Ms. McMurry reported being a cofounder of Pryzm Health outside the submitted work. Dr. Pfaff reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Haendel reported receiving grants from the NIH during the conduct of the study. Dr. Chute reported receiving grants from the NIH/NCATS during the conduct of the study. No conflicts of interest reported for all other authors.

Funding Statement

Declaration of Interests / Conflict of Interest Disclosures: Dr. Bennett reported receiving grants from the National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) during the conduct of the study and grants from the NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development and NIH/National Institute of Allergy and Infectious Diseases outside the submitted work. Dr. Moffitt reported receiving grants from the NIH during the conduct of the study. Dr. Hajagos reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Bradwell reported being employed by Palantir Technologies during the conduct of the study and outside the submitted work. Ms. Gabriel reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Girvin reported being an employee of Palantir Technologies. Ms. McMurry reported being a cofounder of Pryzm Health outside the submitted work. Dr. Pfaff reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Haendel reported receiving grants from the NIH during the conduct of the study. Dr. Chute reported receiving grants from the NIH/NCATS during the conduct of the study. No conflicts of interest reported for all other authors. Funding / Support: The primary study sponsors are multiple institutes of the U.S. National Institutes of Health. The National Center for Advancing Translational Sciences is the primary steward of the N3C data and created the underlying architecture of the N3C Data Enclave, manages the Data Transfer Agreements and Data Use Agreements, houses the Data Access Committee, and supports contracts to vendors to help build various aspects of the N3C Data Enclave. Employees of the NIH and of the contracting companies are included as authors of the manuscript and participated in the writing and decision to submit the manuscript. The analyses for this work were conducted using data and tools accessed through the NCATS N3C Data Enclave and supported by NCATS U24 TR002306 (Drs Haendel, Chute, and Saltz; also supporting Dr. Pfaff, Ms. Walden, Ms. McMurry, Mr. Neumann and Ms. Gabriel). This study was also supported by numerous institutional grants associated with institutions with release data, see supplement for full list of grant numbers and institutions.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The N3C data transfer to NCATS is performed under a Johns Hopkins University Reliance Protocol # IRB00249128 or individual site agreements with NIH. Use of the N3C data for this study is authorized under the following IRB Protocols: - Site: University of Colorado; IRB Name: Colorado Multiple Institutional Review Board; Exempted vs approved: approved; Protocol Number:20-2225 - Site: Johns Hopkins University; IRB Name: Johns Hopkins Office of Human Subjects Research, Institutional Review Board ; Exempted vs approved: approved; Protocol number: IRB00249128 - Site: University of North Carolina; IRB name: University of North Carolina Chapel Hill Institutional Review Board; Exempted vs approved: exempted; Protocol number: 20-3106 - Site: Stony Brook University; IRB name: Office of Research Compliance, Division of Human Subject Protections, Stony Brook University; Exempted vs approved: exempted; Protocol number: IRB2020-00604

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes